{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:46:02Z","timestamp":1764510362304,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2259,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.bbmt.2008.11.015","type":"journal-article","created":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T05:06:28Z","timestamp":1232687188000},"page":"205-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["IPSS Poor-Risk Karyotype as a Predictor of Outcome for Patients with Myelodysplastic Syndrome following Myeloablative Stem Cell Transplantation"],"prefix":"10.1016","volume":"15","author":[{"given":"Thomas J.","family":"Nevill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather J.","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasser R.","family":"Abou Mourad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julye C.","family":"Lavoie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen H.","family":"Nantel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia L.","family":"Toze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna E.","family":"Hogge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna L.","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin W.","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryse M.","family":"Power","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet Y.","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunfeng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clayton A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2008.11.015_bib1","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1056\/NEJMp048266","article-title":"Myelodysplastic syndromes\u2014coping with ineffective hematopoiesis","volume":"352","author":"Cazzola","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2008.11.015_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/10428199509051708","article-title":"An update on allogeneic marrow transplantation for myelodysplastic syndrome","volume":"17","author":"Anderson","year":"1995","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2008.11.015_bib3","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1200\/JCO.1995.13.12.2973","article-title":"Busulfan\/cyclophosphamide as conditioning regimen fior allogeneic bonwe marrow transplantation for myelodysplasia","volume":"13","author":"O'Donnell","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2008.11.015_bib4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1182\/blood.V88.1.358.358","article-title":"Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients","volume":"88","author":"Sutton","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.015_bib5","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1182\/blood.V92.6.1910","article-title":"Cytogenetic abnormalities in primary myelodysplastic syndromes are highly predictive of outcome after allogeneic bone marrow transplantation","volume":"92","author":"Nevill","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.015_bib6","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1046\/j.1365-2141.2000.02200.x","article-title":"Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Boner Marrow Transplatation","volume":"110","author":"de Witte","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2008.11.015_bib7","first-page":"1997","article-title":"Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia","volume":"100","author":"Sierra","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.015_bib8","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood-2002-02-0527","article-title":"Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome","volume":"100","author":"Deeg","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.015_bib9","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood.V85.6.1655.bloodjournal8561655","article-title":"Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor","volume":"856","author":"Bensinger","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.015_bib10","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood.V85.6.1666.bloodjournal8561666","article-title":"Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor)","volume":"85","author":"Schmitz","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.015_bib11","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1182\/blood.V85.6.1659.bloodjournal8561659","article-title":"Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts","volume":"85","author":"Korbling","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.015_bib12","first-page":"3702","article-title":"Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation","volume":"95","author":"Champlin","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.015_bib13","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(00)02090-0","article-title":"Allogeneic blood and bone marrow stem cell transplantation in haematological malignant diseases: a randomized trial","volume":"355","author":"Powles","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2008.11.015_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJM200101183440303","article-title":"Transplantation of bone marrow as compared with peripheral blood cells from HLA-identical relatives in patients with hematologic cancers","volume":"344","author":"Bensinger","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2008.11.015_bib15","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood-2002-01-0048","article-title":"A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies","volume":"100","author":"Couban","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.015_bib16","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1182\/blood.V90.12.4705","article-title":"Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease","volume":"90","author":"Storek","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.015_bib17","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1182\/blood.V98.6.1695","article-title":"Chronic graft-versus-host disease after allogeneic blood stem cell transplantation","volume":"98","author":"Przepiorka","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.015_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/sj.bmt.1703778","article-title":"Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow","volume":"31","author":"Garderet","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.11.015_bib19","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.bbmt.2007.08.006","article-title":"Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival","volume":"13","author":"Eapen","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.11.015_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2008.11.015_bib21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1182\/blood.V94.2.455","article-title":"Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation","volume":"94","author":"Ringd\u00e9n","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.015_bib22","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.015_bib23","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.7326\/0003-4819-111-12-1049_2","article-title":"Busulphan and phenytoin","volume":"111","author":"Grigg","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2008.11.015_bib24","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1200\/JCO.1991.9.11.2016","article-title":"Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation","volume":"9","author":"Shepherd","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2008.11.015_bib25","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1182\/blood.V79.11.2834.bloodjournal79112834","article-title":"Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion low-dose heparin: a prospective, randomized trial","volume":"79","author":"Attal","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.015_bib26","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJM198603203141201","article-title":"Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia","volume":"314","author":"Storb","year":"1986","journal-title":"N Engl J Med"},{"issue":"Suppl B","key":"10.1016\/j.bbmt.2008.11.015_bib27","first-page":"58","article-title":"Depletion of CD3+ cells from allogeneic bone marrow grafts using high gradient magnetic separation","volume":"17","author":"Thomas","year":"1994","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.bbmt.2008.11.015_bib28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in hman recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2008.11.015_bib29","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.bbmt.2008.11.015_bib30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.bbmt.2008.11.015_bib31","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"key":"10.1016\/j.bbmt.2008.11.015_bib32","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/bimj.200410152","article-title":"A note on including time-dependent covariate in regression model for competing risks data","volume":"47","author":"Latouche","year":"2005","journal-title":"Biometrics"},{"key":"10.1016\/j.bbmt.2008.11.015_bib33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc B"},{"issue":"Suppl 1","key":"10.1016\/j.bbmt.2008.11.015_bib34","first-page":"25","article-title":"Allogeneic marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS score","volume":"12","author":"Appelbaum","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2008.11.015_bib35","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/sj.bmt.1702051","article-title":"Allogeneic blood stem cell and bone marrow transplantation for acute myelogenous leukemia and myelodysplasia: influence of stem cell source on outcome","volume":"24","author":"Russell","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.11.015_bib36","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1182\/blood.V99.12.4370","article-title":"Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes","volume":"99","author":"Guardiola","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.015_bib37","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/sj.bmt.1704246","article-title":"Peripheral blood is safer than bone marrow as a source of hematopoietic progenitors in patients with myelodysplastic syndromes who receive an allogeneic transplantation. Results from the Spanish registry","volume":"32","author":"del Ca\u00f1izo","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.11.015_bib38","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1182\/blood.V98.6.1739","article-title":"No difference in graft-versus-host disease, relapse, and survival comparing peripheral blood stem cells to bone marrow using unrelated donors","volume":"98","author":"Remberger","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.015_bib39","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood.V99.4.1130.h8001130_1130_1135","article-title":"Improved disease-free-survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia","volume":"99","author":"Elmaagacli","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.015_bib40","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.2000.18.5.963","article-title":"Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients\u2014report of the French Society of Bone Marrow Transplantation","volume":"18","author":"Yakoub-Agha","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2008.11.015_bib41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bbmt.2004.10.001","article-title":"Pretransplantation induction chemotherapy and posttransplantation relapse in patients with advanced myelodysplastic syndrome","volume":"11","author":"Scott","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.11.015_bib42","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2002-02-0400","article-title":"Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes","volume":"100","author":"Martino","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.015_bib43","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1182\/blood-2003-11-3750","article-title":"Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation","volume":"104","author":"de Lima","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.015_bib44","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/sj.leu.2404010","article-title":"Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis","volume":"20","author":"Scott","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2008.11.015_bib45","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/sj.leu.2404037","article-title":"Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity","volume":"20","author":"Shimoni A Hardan","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2008.11.015_bib46","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00277-003-0654-9","article-title":"Allogeneic stem cell transplantation after a fludarabine\/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia","volume":"82","author":"Kr\u00f6ger","year":"2003","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2008.11.015_bib47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2141.2006.06272.x","article-title":"Outcomes of alemtuzumab-based reduced intensity conditioning stem cell transplantation using unrelated donors for myelodysplastic syndromes","volume":"135","author":"Lim","year":"2006","journal-title":"Br J\u00a0Haematol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387910800503X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387910800503X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:32:40Z","timestamp":1761057160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108387910800503X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S108387910800503X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2008.11.015","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2009,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IPSS Poor-Risk Karyotype as a Predictor of Outcome for Patients with Myelodysplastic Syndrome following Myeloablative Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2008.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}